CDMO News AGC Biologics Secures Multi-Year Yokohama Manufacturing Contract Worth Hundreds of Millions 29 July 2026
CDMO News Bachem to Invest More Than CHF 500 Million(US$620M) in Sisslerfeld Manufacturing Site 24 July 2026
CDMO News Cytovance Biologics Expands Upstream Process Development with Perfusion Capabilities 16 July 2026
CDMO News WuXi Biologics’ Hebei Facility Passes FDA Pre-License Inspection for Autoimmune Therapy 10 July 2026